A comprehensive analysis of SRSF9 mRNA levels in TCGA database identified significant upregulation of SRSF9 in various cancers, notably in GBM, breast cancer, and lung squamous cell carcinoma, with tumor tissues exhibiting markedly higher levels than adjacent normal tissues (Fig. 1A, B). Here, SRSF9 is linked to glioblastoma.